000			02097cam a22005774a 4500
999			_c20042 _d20042
001			14431750
003			OSt
005			20250929062653.0
008			060628s2005 gw a b 001 0 eng c
010			_a 2006278376
015			_aGBA589210 _2bnb
016	7		_a101258041 _2DNLM
016	7		_a974288438 _2GyFmDB
016	7		_a013312879 _2Uk
020			_a3527311874 _qalk. paper
020			_a9783527311873
035			_a14431750
035			_a(OCoLC)61430052
040			_aNLM _cNLM _dOHX _dBAKER _dUKM _dORE _dAGL _dDLC
042			_apcc
050	0	0	_aQR189.5.D53 _bD628 2005
060	0	0	_a2005 L-378
060	1	0	_aQV 748 _bD629 2005
070	0		_aQR189.5.D53 _bD63 2005
072		7	_aRM _2lcco
072		7	_aRS _2lcco
082	0	0	_a615.19 _223
100			_aSchleef Martin
245	0	0	_aDNA pharmaceuticals : _bformulation and delivery in gene therapy, DNA vaccination and immunotherapy / _cedited by Martin Schleef.
260			_aWeinheim : _bWiley-VCH, _cc2005.
300			_axxii, 253 p. : _bill. (some col.) ; _c25 cm.
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index.
650		0	_aDNA vaccines.
650		0	_aGene therapy.
650		0	_aImmunotherapy.
650	1	2	_aPharmaceutical Preparations _xadministration & dosage.
650	2	2	_aGene Therapy.
650	2	2	_aImmunotherapy.
650	2	2	_aVaccines, DNA _xadministration & dosage.
700	1		_aSchleef, M. _q(Martin)
856	4	2	_3Contributor biographical information _uhttp://www.loc.gov/catdir/enhancements/fy0650/2006278376-b.html
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0650/2006278376-d.html
856	4	1	_3Table of contents only _uhttp://www.loc.gov/catdir/enhancements/fy0650/2006278376-t.html
906			_a7 _bcbc _cpccadap _d2 _encip _f20 _gy-gencatlg
942			_2ddc _cBK